Since 2005 we have been managing clinical trials in Central and Eastern Europe and the CIS for pharma and biotech clients from around the world.
We are proud and humbled by the trust our sponsors have placed in us since 2005. Our full range of CRO services has helped sponsors worldwide in offshoring their clinical trials and bringing their innovative treatments to market.
Take a look at a fraction of our sponsor roster which includes a variety of pharmaceutical and biotech companies from across the world.
We'd like to express our gratitude to the OCT team for having successfully completed our study and achieving patient recruitment target ahead of the schedule.
The OCT Clinical team met our goals under very difficult conditions. The achievement is quite impressive, considering the challenging circumstances imposed by the global pandemic.
We are happy with the results OCT Clinical has been demonstrating as the principal CRO for the project.
OCT Clinical’s ability to meet our recruitment needs within our timeline, especially through the summer months, impressed us.
We are pleased to once again work with the professional OCT Clinical team as we continue to generate important scientific evidence related to our MED3000 gel.
For references and our current client line-up, please contact info@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
